Literature DB >> 17250717

CSF analysis in patients with sporadic CJD and other transmissible spongiform encephalopathies.

A Green1, P Sanchez-Juan, A Ladogana, N Cuadrado-Corrales, R Sánchez-Valle, E Mitrová, K Stoeck, T Sklaviadis, J Kulczycki, U Heinemann, K Hess, D Slivarichová, A Saiz, M Calero, V Mellina, R Knight, C M van Duijn, I Zerr.   

Abstract

Patients with suspected Creutzfeldt-Jakob disease (CJD) often have routine cerebrospinal fluid (CSF) analysis performed to exclude treatable inflammatory conditions; however, little information is available about the range of results obtained for CSF tests in patients with sporadic CJD and other transmissible spongiform encephalopathies (TSE). Data from 450 patients with sporadic CJD and 47 patients with other TSEs were collected as part of an EC-supported multinational study. Raised white cell counts of >5 cells/microl were found in three of 298 patients with sporadic CJD, with two cell counts of 7 cells/microl and one of 20 cells/microl. Total protein concentrations of >0.9 g/l were found in five of 438 patients with sporadic CJD, although none had a concentration of >1 g/l. CSF oligoclonal IgG was detected in eight of 182 sporadic CJD patients. Of the patients with other TSEs, six had elevated cell counts ranging from 6 to 14 cells/microl but none had total protein concentrations of >0.9 g/l and one patient had detectable oligoclonal IgG. None of the patients with sporadic CJD or other TSEs had abnormalities in all three tests.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17250717     DOI: 10.1111/j.1468-1331.2006.01630.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  14 in total

Review 1.  NMDA receptor autoantibodies in sporadic Creutzfeldt-Jakob disease.

Authors:  Graham Mackay; Kate Ahmad; Jon Stone; Cathie Sudlow; David Summers; Richard Knight; Robert Will; Sarosh R Irani; Angela Vincent; Paul Maddison
Journal:  J Neurol       Date:  2012-04-18       Impact factor: 4.849

2.  CSF pleocytosis and syndrome of inappropriate antidiuretic hormone secretion in Creutzfeldt-Jakob disease.

Authors:  Ali G Hamedani; Hannah C McLane; Grace Kimbaris; Dina A Jacobs; Joseph R Berger
Journal:  Neurol Clin Pract       Date:  2016-08

3.  Tau and 14-3-3 of genetic and sporadic Creutzfeldt-Jakob disease patients in Israel.

Authors:  Zeev Meiner; Esther Kahana; Fanny Baitcher; Amos D Korczyn; Joab Chapman; Oren S Cohen; Ron Milo; Judith Aharon-Perez; Oded Abramsky; Ruth Gabizon; Hanna Rosenmann
Journal:  J Neurol       Date:  2010-09-09       Impact factor: 4.849

Review 4.  Prion Diseases.

Authors:  Michael D Geschwind
Journal:  Continuum (Minneap Minn)       Date:  2015-12

5.  Diagnosis and treatment of rapidly progressive dementias.

Authors:  Ross W Paterson; Leonel T Takada; Michael D Geschwind
Journal:  Neurol Clin Pract       Date:  2012-09

Review 6.  Sporadic and Infectious Human Prion Diseases.

Authors:  Robert G Will; James W Ironside
Journal:  Cold Spring Harb Perspect Med       Date:  2017-01-03       Impact factor: 6.915

7.  Detection of Prions in Brain Homogenates and CSF Samples Using a Second-Generation RT-QuIC Assay: A Useful Tool for Retrospective Analysis of Archived Samples.

Authors:  Tibor Moško; Soňa Galušková; Radoslav Matěj; Magdalena Brůžová; Karel Holada
Journal:  Pathogens       Date:  2021-06-13

8.  Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years.

Authors:  Katharina Stoeck; Pascual Sanchez-Juan; Joanna Gawinecka; Alison Green; Anna Ladogana; Maurizio Pocchiari; Raquel Sanchez-Valle; Eva Mitrova; Theodor Sklaviadis; Jerzy Kulczycki; Dana Slivarichova; Albert Saiz; Miguel Calero; Richard Knight; Adriano Aguzzi; Jean-Louis Laplanche; Katell Peoc'h; Gabi Schelzke; Andre Karch; Cornelia M van Duijn; Inga Zerr
Journal:  Brain       Date:  2012-09-25       Impact factor: 13.501

9.  Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease.

Authors:  I Zerr; K Kallenberg; D M Summers; C Romero; A Taratuto; U Heinemann; M Breithaupt; D Varges; B Meissner; A Ladogana; M Schuur; S Haik; S J Collins; Gerard H Jansen; G B Stokin; J Pimentel; E Hewer; D Collie; P Smith; H Roberts; J P Brandel; C van Duijn; M Pocchiari; C Begue; P Cras; R G Will; P Sanchez-Juan
Journal:  Brain       Date:  2009-09-22       Impact factor: 13.501

10.  Rapidly progressive dementia and ataxia in an elderly man.

Authors:  Rebekah M Ahmed; G Michael Halmagyi; Michael L Rodriguez
Journal:  Pract Neurol       Date:  2013-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.